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Abstract
The spread of multidrug-resistance in Gram-negative bacterial pathogens presents a major clinical challenge, and new 
approaches are required to combat these organisms. Nitric oxide (NO) is a well-known antimicrobial that is produced by 
the immune system in response to infection, and numerous studies have demonstrated that NO is a respiratory inhibitor 
with both bacteriostatic and bactericidal properties. However, given that loss of aerobic respiratory complexes is known to 
diminish antibiotic efficacy, it was hypothesised that the potent respiratory inhibitor NO would elicit similar effects. Indeed, 
the current work demonstrates that pre-exposure to NO-releasers elicits a > tenfold increase in  IC50 for gentamicin against 
pathogenic E. coli (i.e. a huge decrease in lethality). It was therefore hypothesised that hyper-sensitivity to NO may have 
arisen in bacterial pathogens and that this trait could promote the acquisition of antibiotic-resistance mechanisms through 
enabling cells to persist in the presence of toxic levels of antibiotic. To test this hypothesis, genomics and microbiological 
approaches were used to screen a collection of E. coli clinical isolates for antibiotic susceptibility and NO tolerance, although 
the data did not support a correlation between increased carriage of antibiotic resistance genes and NO tolerance. However, 
the current work has important implications for how antibiotic susceptibility might be measured in future (i.e. ± NO) and 
underlines the evolutionary advantage for bacterial pathogens to maintain tolerance to toxic levels of NO.
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Introduction
For the last eight decades, antibiotics have been used to com-
bat infectious diseases. However, their widespread use has 
led to the emergence of bacterial pathogens with increased 
resistance to antimicrobial agents, leading to an increase in 
mortality and morbidity. Recently, the emergence of multi-
drug-resistance (i.e. to three or more antibiotic classes) in 
Gram-negative pathogens has become a cause for concern, 
with several Gram-negative bacteria, including E. coli, found 
to be NDM-1 β-lactamase-producing (Walsh et al. 2011). 
These strains often carry many other resistant determinants 
resulting in extreme multidrug-resistant phenotypes (Yong 
et al. 2009). Of particular concern is bacteraemia caused 
by E. coli, where there are approximately 40,000 annual 
cases in England. Over one-third of these are caused by 
drug-resistant strains causing close to 5,000 deaths each 
year (Public Health England). An over-represented clonal 
group is E. coli ST131, a uropathogen first identified in 2008 
(Nicolas-Chanoine et al. 2008) that is now globally dissemi-
nated in both hospital and community settings and has a high 
incidence of CTX-M-15 extended-spectrum β-lactamase 
(ESBL)-producing isolates (Croxall et al. 2011; Nicolas-
Chanoine et al. 2014). Given the apparent ease with which 
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multidrug-resistant E. coli are able to spread throughout the 
human population, it is important to understand elements 
of the host environment and bacterial physiology that could 
potentially subvert the efficacy of antibiotics. Indeed, the 
ability of a bacterium to respire has a profound impact upon 
antibiotic function and is, therefore, a major focus of the 
current study. A recent study has shown that the abolition 
of aerobic respiration (reviewed in (Stokes et al. 2019)), dra-
matically reduces the toxic effects of bactericidal antibiotics 
(Lobritz et al. 2015). It, therefore, seems reasonable that 
a potent respiratory inhibitor such as a nitric oxide (NO), 
which is produced by the host immune system during infec-
tion, would also impair antibiotic efficacy.
It is well-known that bactericidal antibiotics can induce 
cell death via activation of pathways that result in oxidative 
damage via elevation of aerobic respiratory rates (Dwyer 
et al. 2007, 2014; Foti et al. 2012), with superoxide pro-
duction implicated as a key intermediate: superoxide causes 
destabilisation of iron-sulphur complexes (Imlay and Fri-
dovich 1991; Keyer and Imlay 1996) which causes iron 
dysregulation and, more importantly, leaching of ferrous 
iron. Subsequent reactions of leached ferrous iron reduce 
hydrogen peroxide to toxic hydroxyl radicals via the Fenton 
reaction (Imlay et al. 1988). Although different bactericidal 
antibiotics have different modes of action, Kohanski and col-
leagues (Kohanski et al. 2007, 2010) identified that most are 
able to induce the formation of hydroxyl radicals which is 
thought to be linked to the aerobic respiratory chain. How-
ever, for aminoglycosides, there is significant evidence to 
support a link between the proton motive force and antibiotic 
toxicity that is independent of ROS formation: uptake of 
positively charged aminoglycosides is linked to the electrical 
component of the proton motive force, as transport into the 
cell is thermodynamically favourable as the charge com-
ponent of the PMF will be dissipated upon antibiotic entry 
(Taber et al. 1987; Farha et al. 2018).
Aside from the potential role in disrupting the potency 
of antibiotics, the primary function of NO in the immune 
response is to act as a toxic antimicrobial to combat infec-
tion. Cellular targets for NO include thiols, metal centres, 
haem cofactors, and cysteine residues of proteins that are 
susceptible to S-nitrosylation (Fang 1997; Keszler et al. 
2010). Bacteria have encountered NO in the gut and at the 
local site of infection for millennia, and have predictably 
evolved a variety of mechanisms to circumvent this toxic-
ity (Shepherd et al. 2016), including detoxification systems 
to convert NO to less toxic substances, NO-tolerant res-
piratory oxidases, and mechanisms to repair damaged iron 
sulphur clusters. Hence, an assumption made in the current 
study is that bacterial exposure to NO and the evolution of 
resistance to this toxic molecule pre-dates the widespread 
exposure to antibiotics and the resultant emergence of anti-
biotic resistance. Given that loss of aerobic respiratory 
complexes had previously been shown to diminish the 
efficacy of various antibiotics (Lobritz et al. 2015), it was 
anticipated that the respiratory inhibitor NO would also 
diminish antibiotic susceptibility. If this could be dem-
onstrated, we hypothesised that hyper-sensitivity to NO 
may have arisen in bacterial pathogens as a mechanism to 
promote the acquisition of antibiotic-resistance through 
enabling cells to persist in the presence of toxic levels 
of antibiotic (Fig. 1). Hence, the current work sought to 
investigate the relationship between NO tolerance/sensi-
tivity and carriage of antibiotic resistance genes and to 
characterise the impact of NO upon the efficacy of conven-
tional antibiotics against E. coli clinical isolates.
Materials and methods
Bacterial isolates
Fifty E. coli blood culture isolates were collected from 
East Kent Hospitals University NHS Foundation Trust. 
Approval was sought from the Research Ethics Council in 
advance (ref: 12/SC/0673) for this fully-blinded study. E. 
coli CFT073 is a highly invasive UPEC strain and a causa-
tive agent of pyelonephritis (Mobley et al. 1990; Welch 
et al. 2002), E. coli 83972 is asymptomatic bacteriuria 
(ABU) strain capable of out-competing UPEC strains 
(Roos et  al. 2006), and EC958 is a well-characterised 
O25: H4-ST131 multidrug-resistant urosepsis-causing 
strain (Totsika et al. 2013; Forde et al. 2014). EC958 Cm-
cassette insertional mutant strains norVW and hmp have 
been described previously (Shepherd et al. 2016).
Fig. 1  Initial hypotheses for the co-evolution of NO sensitivity and 
antibiotic resistance gene carriage
Archives of Microbiology 
1 3
Genomics analyses
Multilocus sequence typing (MLST) was performed using 
the Achtman approach as previously described (Maiden 
et al. 1998; Clark et al. 2012). A minimum spanning tree was 
created based on the MLST data using BioNumerics version 
7.5 created by Applied Maths NV. Bacterial genomes were 
sequenced using an Illumina MiSeq instrument, and reads 
were assembled de novo using SPAdes Genome Assembler 
(Bankevich et al. 2012), after which the genomes were re-
ordered with the software Mauve (v2.4.0) (Darling et al. 
2004) and using the well-characterised genome E. coli 
MG1655 (NC_000913.3) as reference. The newly re-ordered 
genomes were annotated with Prokka (v1.12) (Seemann 
2014). Pan-genome analysis was accomplished with Roary 
(Page et al. 2015), and the core genome obtained was used 
as input in FastTree (Price et al. 2009) to create a phylo-
genetic tree of all the isolates of the Kent Collection, and 
edited with iTOL v3 (Letunic and Bork 2016). Genomes 
were mined for virulence genes using ABRicate (v0.8) (https 
://githu b.com/tseem ann/abric ate) to search the VFDB data-
base (Chen et al. 2005). Protein sequences were aligned with 
T- Coffee (Notredame et al. 2000; Di Tommaso et al. 2011) 
and the values for protein identity and similarity of each 
pairwise alignment were extracted with BioEdit v7.2.5. For 
phylogenetic group determination, the Clermont method 
was used (Clermont et al. 2013, 2015). Briefly, the genomic 
sequence of each isolate was concatenated in FASTA for-
mat and used for in silico PCR using Unipro UGENE plat-
form (Okonechnikov et al. 2012) with the primer sequences 
used by Clermont et al. (Clermont et al. 2013). To predict 
antibiotic susceptibility using genomic data, genomes were 
mined for antibiotic resistance genes with ABRicate (https 
://githu b.com/tseem ann/abric ate) to search the ResFinder 
2.1 database (Zankari et al. 2012). For in silico detection 
of aminoglycoside resistance, the protein sequences of the 
gyrase subunit A for all genomes were aligned with T-Coffee 
(Notredame et al. 2000; Di Tommaso et al. 2011) and chro-
mosomal mutations known to elicit resistance (Weigel et al. 
1998; McArthur et al. 2013; Jia et al. 2017) were manually 
detected.
Antimicrobial susceptibility assays
The British Society for Antimicrobial Chemotherapy (BSAC) 
method for antibiotic susceptibility testing was used to prepare 
standardised inoculum (Andrews 2001, 2002) and for break-
point values (i.e. antimicrobial threshold concentrations that 
define resistance/susceptibility). Antimicrobial susceptibility 
profiles of E. coli clinical isolates were obtained for amoxi-
cillin (AMX) (Sigma), cefotaxime (CTX) (Sigma), chloram-
phenicol (CAP) (ThermoFisher), ciprofloxacin (CIP) (Fluka), 
meropenem (MEM) (Sigma), nitrofurantoin (NIT) (Sigma), 
and trimethoprim (TMP) (Sigma) using the disc diffusion 
method. Due to poor agar diffusion, the susceptibility of the 
clinical isolates to polymyxin E (PME) (Sigma) was deter-
mined using the minimum inhibitory concentration (MIC) 
method.
Gentamicin dose response assays
Cultures of EC958 wild type were grown to stationary phase 
overnight in LB at 37 °C. 10 mL volumes of M9 media (16 g/L 
 Na2HPO4.2H2O, 3 g/L  KH2PO4, 0.5 g/L NaCl, 1 g/L  NH4Cl, 
0.24 g/L  MgSO4, 0.01 g/L  CaCl2, and 4 g/L glucose) sup-
plemented with 0.1% casamino acids (w/v) were prepared in 
50 mL conical flasks and inoculated with 1% (v/v) of the sta-
tionary phase cultures, and incubated at 37 °C, 180 rpm until 
mid-exponential phase. From these cultures, suspensions of 
 108 CFU/mL were prepared in fresh M9 media supplemented 
with 0.1% casamino acids and exposed to GSNO (0 or 15 mM) 
or NOC-12 (0 or 1 mM) for 30 min at 37 °C, prior to incuba-
tion with different concentrations of gentamicin for 90 min. 
Serial dilutions were performed in 1 × PBS and cells were 
plated in triplicate on LB-agar plates. Colony counts were 
performed after overnight incubation at 37 °C. Two biological 
repeats were performed for each condition, with three technical 
repeats performed for each biological repeat (i.e. 6 in total).
Nitric oxide susceptibility assays
Nitric oxide susceptibility was evaluated using a well diffu-
sion assay. Briefly, cultures at mid-exponential growth were 
prepared in M9 minimal medium supplemented with 0.1% 
casamino acids, using a 1% inoculum of stationary phase 
aerobic culture prepared in LB medium at 37 °C. When mid-
log phase was reached, cells were plated on M9 minimal agar 
medium using the pour plate technique. Six 6 mm diameter-
wells were cut in the agar gel and 80 µL of 80 mM S-Nitroso-
glutathione (GSNO), synthesised and quantified as previously 
described (Hart 1985), was added to each. Plates were incu-
bated at 37 °C under aerobic, microaerobic (2% oxygen) or 
anaerobic conditions. For anaerobic growth, 50 mM fumarate 
was included in the agar. For microaerobic growth, oxygen 
levels were controlled using a Ruskinn Invivo 300 Hypoxia 
Workstation and for anaerobic growth, plates were incubated 
in anaerobic jars with an anaerobic gas pouch (Oxoid) and 
oxygen indicator (Oxoid). Zones of inhibition were measured 
after 16 h incubation, and data were analysed using a two-
tailed unpaired Student’s t-test.
 Archives of Microbiology
1 3
Results
Nitric oxide diminishes antibiotic efficacy
It has previously been demonstrated that NO protects Sal-
monella enterica, Pseudomonas aeruginosa and Staphy-
lococcus aureus from aminoglycosides by blocking the 
energy-dependent phases of drug uptake (McCollister 
et al. 2011), although no detailed analyses were under-
taken to measure the impact upon antibiotic  IC50 values, 
and no work was undertaken on pathogenic E. coli. Hence, 
a gentamicin dose response killing experiment was con-
ducted with the multidrug-resistant E. coli O25b:H4-
ST131 (EC958) strain (Totsika et al. 2013; Forde et al. 
2014) using the NO-donor GSNO. Pre-exposure of an 
exponentially-growing culture of EC958 to 15 mM GSNO 
for 30 min, prior to the addition of increasing gentamicin 
concentrations for 90  min, led to a dramatic increase 
in bacterial survival (Fig. 2a) with the  IC50 increasing 
approximately tenfold for cells pre-exposed to GSNO. To 
confirm that this effect was due to the presence of NO, a 
similar experiment was performed with 1 mM NOC-12 in 
place of GSNO (Fig. 2b), which confirmed the same pat-
tern with a slightly more pronounced effect: pre-treatment 
with NOC-12 resulted in a 16-fold increase in the  IC50 of 
gentamicin. A GSNO-mediated increase in  IC50 was also 
observed under anaerobic conditions (Fig. S1), and it was 
also noted that a switch to anaerobiosis elicited a > ten-
fold increase in the  IC50 for gentamicin in the absence of 
GSNO.
No detectable correlation exists 
between antibiotic‑resistance gene carriage 
and nitric oxide susceptibility in E. coli clinical 
isolates
To investigate the potential relationship between antibi-
otic-resistance gene carriage and NO-mediated respira-
tory inhibition, it was necessary to perform genomic and 
phenotypic analysis of E. coli clinical isolates. Fifty E. 
coli bacteraemia isolates were collected from the Clini-
cal Microbiology Service at The William Harvey Hos-
pital (Ashford, Kent) in a double-blinded study, and will 
be herein referred to as the Kent Collection (KC). MLST 
analysis performed on KC isolates identified a total of 23 
unique sequence types (STs), with the most prevalent STs 
ST73, ST69, and ST131, accounting for 18%, 14%, and 
12% of the collection, respectively (Fig. S2). Isolates were 
sequenced using the Illumina MiSeq platform, and phylo-
genetic analysis with Roary (Page et al. 2015) was used 
to perform phylogroup clustering based on core genomes 
(Clermont et al. 2013, 2015) (Fig. 3a). To characterise 
antibiotic susceptibility and resistance gene carriage in 
this collection, a combination of in silico and labora-
tory techniques were employed. This dual approach was 
undertaken as in silico techniques could be used to rapidly 
screen all isolates for resistance to many classes of anti-
biotic, and then the more labour intensive experimental 
laboratory approach was undertaken on a subset of the 
antibiotics to validate the in silico results. These analy-
ses revealed that 14% of the collection exhibited multi-
drug resistance (i.e. resistant to three or more antibiotic 
classes), with three such isolates belonging to the ST131 
clonal group (Fig. 3a, outer ring). Furthermore, 6% were 
CTX-M-15 ESBL-producing isolates, and susceptibility to 
amoxicillin, trimethoprim, and ciprofloxacin was found in 
Fig. 2  Nitric oxide releasers abrogate the lethality of gentamicin. 
Suspensions of  108 cells/mL of E. coli EC958 in M9 minimal media 
supplemented with 0.1% casamino acids were exposed to 15  mM 
GSNO (a) and 1 mM NOC-12 (b) for 30 min, followed by incubation 
with different concentrations of gentamicin for 90  min. Serial dilu-
tions were performed in PBS and plated on LB-agar. CFU/mL values 
were determined after overnight incubation at 37 °C. Data were fitted 
to a four parameter Hill equation for calculation of  IC50 values, and 
magnitude changes were normalised to 100% for display on a linear 
y-axis (insets). Values shown represent mean ± SD from two biologi-
cal repeats, each comprising three technical repeats
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42%, 28%, and 16% of the isolates, respectively. Resist-
ance data for the most prevalent STs, which are also the 
clonal groups with the highest degree of antibiotic resist-
ance (i.e. ST131, ST69, ST73), are shown in Fig. 3b.
To investigate potential correlations between antibiotic 
resistance and tolerance to NO, isolates that exhibited the 
highest degree of antibiotic resistance for each ST were 
selected (Fig. 4a), and susceptibility to the NO-releasing 
molecule GSNO was measured both in the presence (aero-
bic and microaerobic) and absence (anaerobic) of oxygen 
(Fig. 4b). Well-characterised E. coli clinical isolates EC958 
(Totsika et al. 2013; Forde et al. 2014), CFT073 (Mob-
ley et al. 1990; Welch et al. 2002) and 83,972 (Roos et al. 
2006) were also analysed as control samples and known 
NO-sensitive mutant strains were confirmed to have larger 
zones of inhibition to validate the technique (Fig. S3). Out 
of the 13 strains tested, none of the isolates displayed a sig-
nificant increase in NO tolerance compared to the control 
strains (Student’s unpaired two-tailed t-tests), and only one 
isolate (KC45) exhibited significantly higher susceptibil-
ity to NO than all other strains (P-value ≤ 0.001) under 
both aerobic and microaerobic conditions tested. However, 
further assessment of NO-sensitivity using the alternative 
NO-releasing compound NOC-12 revealed no sensitivity 
(Fig. S4), suggesting that this KC45 isolate is sensitive to a 
GSNO breakdown product other than NO. For this reason, 
the KC45 strain was omitted from the correlation analyses 
between antibiotic resistance and GSNO sensitivity for the 
different oxygen conditions, where no significant relation-
ship was observed (Fig. 4c). To investigate potential cor-
relations between antibiotic resistance and virulence gene 
carriage, genomic sequences were mined for virulence genes 
(Fig. 5a), although no significant correlation was found 
between the degree of antibiotic resistance and virulence 
profile from the Pearson Correlation Coefficient (Fig. 5b).
Discussion
The antimicrobial properties of nitric oxide are well-known, 
and it has long been considered a potential alternative to 
antibiotics or for use in combination with antibiotics. How-
ever, given the anticipated potent inhibition of respiration 
in the presence of NO in aerobically-growing planktonic 
E. coli cells, it was hypothesised that NO would enhance 
tolerance to antibiotics (Fig. 1). Indeed, pre-exposure of E. 
coli EC958 with the NO-donors GSNO or NOC-12 prior to 
treatment with gentamicin dramatically increased (i.e. > ten-
fold increase in  IC50) bacterial tolerance to this antibiotic 
(Fig. 2). In addition, GSNO was shown to offer significant 
protection to gentamicin in anaerobically-grown cells (Fig. 
S1), which suggests that there are cellular targets for GSNO 
other than respiratory oxidases that can influence tolerance 
to aminoglycosides. Interestingly, the  IC50 for gentamicin 
increased by > tenfold when cells were grown anaerobically 
without GSNO, highlighting the dramatic influence that 
growth conditions can have upon antibiotic susceptibility. 
Given that NO is produced by the host immune system dur-
ing infection, these data should change the way that anti-
biotic susceptibility is studied both during infection and in 
microbiological culture media and it would be particularly 
interesting to re-assess  IC50 values for all antibiotics and all 
organisms via the BSAC method in the presence of NO for 
cells grown both aerobically and anaerobically.
Fig. 3  Antibiotic susceptibilities of E. coli phylogroups and sequence 
types. a Phylogenetic relationships of 50 E. coli clinical isolates were 
inferred using the core genome gene sequences of all isolates (com-
pared to E. coli MG1655) obtained by pan-genome analysis with 
Roary. Phylogroups for each isolate were determined using in silico 
PCR, and each colour represents one phylogroup in the tree (inner 
circle). b Antibiotic resistance profiles were predicted using bioinfor-
matics approaches and were also experimentally screened for antibi-
otic resistance using disc susceptibility testing (Andrews 2001, 2002) 
(the total number of antibiotic classes that each isolate is resistant 
to, based on disc susceptibility, is shown in the outer ring of (a)). ‘% 
antibiotic resistance’ is defined as the % of isolates within a sequence 
type that are resistant to a particular antibiotic. ST sequence type, 
AMX amoxicillin, CTX cefotaxime, CAP chloramphenicol; CIP cip-
rofloxacin, Gen gentamicin, MEM meropenem, NIT nitrofurantoin, 
TMP trimethoprim, PME polymyxin E, MLS macrolides, TET tetra-
cycline, SUL sulfanilamides
 Archives of Microbiology
1 3
Given that both NO and antibiotics are encountered 
during infection, and that susceptibility to NO-mediated 
growth inhibition can prolong exposure of bacteria to anti-
biotics, it was hypothesised that hypersensitivity to NO 
could serve as an evolutionary driver for the acquisition 
of antibiotic resistance genes (Fig. 1). To investigate this, 
genomic characterisation of 50 E. coli bacteraemia isolates 
was undertaken and revealed the three most common STs 
to be ST73, ST69, and ST131 (Fig. 3), which have previ-
ously been shown to be comprised of multidrug-resistant 
strains (Croxall et al. 2011). In this collection, the ST131 
isolates contained a greater incidence of antibiotic resist-
ance compared to ST73, which is consistent with previous 
studies (Johnson et al. 2010; Forde et al. 2014; Nicolas-
Chanoine et al. 2014b). Deletion of all three respiratory 
oxidase complexes in a non-pathogenic strain of E. coli 
has previously been shown to confer tolerance to antibiot-
ics (Lobritz et al. 2015), so it was hypothesised that some 
bacterial isolates may have evolved sensitivity to the res-
piratory inhibitor NO, which could prolong survival in 
Fig. 4  Antibiotic-resistant E. 
coli clinical isolates are not 
resistant/sensitive to NO. a 
Antibiotic resistance profiles 
of the most resistant isolates 
in the KC collection compared 
to MG1655, EC958, CFT073, 
and ABU strain 83972. AMX 
Amoxicillin, CTX Cefotaxime, 
CAP Chloramphenicol, CIP 
Ciprofloxacin, MEM Merope-
nem, NIT Nitrofurantoin, TMP 
Trimethoprim, PME Polymyxin 
E; (−) Sensitive; ( +) Resistant. 
1 N/A Not Applicable. b NO 
susceptibility of antimicrobial-
resistant isolates representa-
tive of STs, under different 
oxygen conditions. Values 
shown are the mean ± SD from 
three experiments. (*Stu-
dent’s t-test unpaired two-tail 
P-value < 0.05). c Linear regres-
sion and correlation between 
GSNO susceptibility and 
antibiotic resistance. Correla-
tion between GSNO susceptibil-
ity and the degree of antibiotic 
resistance (reflected by the 
number of antibiotics to which 
each isolate was experimentally 
resistant to) was calculated 
using the Pearson r for all 
strains in panels A and B except 
KC45 (Pearson r = 0.08, 0.04 
and 0.19 for aerobic, microaero-
bic, and anaerobic conditions 
respectively. P-values of 0.79, 
0.91, and 0.56 were obtained 
for aerobic, microaerobic, and 
anaerobic conditions, respec-
tively). Linear relation between 
the two variables was assessed 
with linear regression, with 
R2 values of 0.007, 0.001, and 
0.035 for aerobic, microaero-
bic, and anaerobic conditions, 
respectively)
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the presence of antibiotics and potentially influence the 
acquisition of antibiotic-resistance genes. However, only 
one of the drug-resistant clinical isolates (KC45) exhibited 
higher sensitivity to GSNO (Fig. 4b), and further experi-
ments with the NO-releaser NOC-12 demonstrated a lack 
of sensitivity to NO (Fig. S4), suggesting that the KC45 
strain is sensitive to an alternative breakdown product of 
GSNO other than NO itself (e.g. possibly glutathione). 
In fact, the KC45 and EC958 clinical isolates were both 
less sensitive to NOC-12 compared to the non-pathogenic 
MG1655 strain. Hence, the KC45 isolate was excluded 
from the correlation analysis (Fig. 4c), which is consistent 
with no relationship between NO sensitivity and antibiotic 
gene carriage. While elevated sensitivity to nitric oxide 
is likely to increase tolerance to antibiotics, a hypothesis 
presents itself that could explain the absence of a ‘NO sen-
sitive’ phenotype in the KC collection: NO sensitivity pro-
vides a selective advantage during exposure to antibiotics, 
but the loss of fitness that accompanies an ‘NO sensitive’ 
phenotype is too detrimental to growth and survival out-
side this niche. Clearly, NO donors have a profound effect 
upon antibiotic susceptibility of the EC958 strain (Fig. 2), 
which possesses a full complement of intact NO tolerance 
machinery. This is consistent with the conclusion that NO 
is sufficiently potent to elicit similar effects against all E. 
coli strains, precluding the selection pressure for the emer-
gence of NO sensitivity phenotype that is accompanied by 
a fitness cost as mentioned above. Hence, the hypothesis 
for co-evolution of NO sensitivity and antibiotic resistance 
gene carriage in Fig. 1 can be rejected and the current 
data can be explained by either of the two possibilities in 
Fig. 6: 1) NO-mediated respiratory inhibition promotes 
the elevated acquisition of antibiotic resistance genes but 
NO sensitivity is not selected for, or 2) NO has no impact 
upon acquisition of antibiotic resistance genes.
Previous work has demonstrated an inverse correlation 
between antibiotic resistance and virulence in S. aureus 
(Sapri et al. 2013) and there are many reports of resistance 
mechanisms affecting virulence (Beceiro et al. 2013), so it 
was of interest to screen this collection for correlations of 
this sort. However, no relationship between virulence and 
antibiotic resistance was observed in the KC collection stud-
ied herein (Fig. 5).
Given the direct toxic effects of NO upon bacterial cells 
(Fig. 2) and the ability of NO to disperse biofilms, NO-
releasing compounds are potentially useful to treat bacte-
rial infections where conventional antibiotics are no longer 
effective. Indeed, a combination of NO releasers and 
ciprofloxacin has previously been shown to be effective 
Fig. 5  Virulence gene profiles of E. coli bacteraemia isolates: no 
correlation with antibiotic resistance. a 50 clinical isolates were 
sequenced and virulence genes were identified using bioinformat-
ics approaches. A selection of genes is shown for the most abundant 
sequence types in the collection. b The correlation between the viru-
lence potential and the degree of antibiotic resistance (reflected by 
the number of different antibiotic classes to which each isolate was 
experimentally resistant to) was investigated by calculating the Pear-
son Correlation Coefficient (Pearson r = −  0.0097; P-value = 0.95). 
Virulence potential is calculated as the % of the 151 virulence 
genes identified that are carried in a given isolate. A relationship 
between the two variables was assessed using linear regression 
(R2 = 9.4 ×  10–5). ST sequence type
Fig. 6  Alternative explanations to explain the relationship between 
NO tolerance and antibiotic resistance gene carriage. Two alternative 
explanations are provided to explain the absence lack of correlation 
observed in the current study between NO sensitivity and antibiotic 
resistance gene carriage
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against E. coli and P. aeruginosa biofilms (de la Fuente-
Núñez et al. 2013; Reffuveille et al. 2015). However, the 
current data show that NO has the opposite effect for gen-
tamicin and planktonic E. coli cells, potentially due to NO-
mediated respiratory inhibition diminishing the efficacy of 
the aminoglycoside gentamicin. More broadly speaking, 
diminished metabolic activity is becoming widely accepted 
to have a profound impact upon antibiotic susceptibility in 
general (Stokes et al. 2019), so the impairment of meta-
bolic activity beyond respiratory metabolism caused by 
NO exposure (e.g. through destruction of iron-sulphur 
clusters and protein S-nitrosation) is likely to reduce the 
efficacy of a variety of antibiotic classes. While no strains 
with increased NO sensitivity were detected herein, no 
strains with increased NO tolerance were present either, 
suggesting that the entire collection would be resistant to 
gentamicin (and other antibiotics) in the presence of NO. 
With the potent effects that NO has upon antibiotic effi-
cacy in clinical isolates in mind, it is clearly important to 
fully understand the combined effects of antibiotic treat-
ments and nitrosative stresses, especially when devising 
new strategies to combat multidrug-resistant strains.
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